COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case reportShort communication Published on 2022-07-012022-10-05 Journal: Journal of neuroimmunology [Category] 바이오마커, 진단, [키워드] adverse event Autoimmune BNT162b2 Case report cause clinical Clinical features clinician Complication Convulsion COVID-19 COVID-19 vaccination described Diagnostic Criteria effective strategy Encephalitis Encephalopathy female Fever immune Laboratory Methylprednisolone mRNA myocarditis notable pandemic of COVID-19 Pathogenesis Patient Pfizer-BioNTech mRNA vaccine Pfizer-BioNTech mRNA vaccine (BNT162b2) Research responsible SARS-CoV-2 second dose significantly the vaccine thought thrombocytopenia vaccination Vaccine-associated encephalopathy [DOI] 10.1016/j.jneuroim.2022.577883 [Article Type] Short communication
Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort studyArticle Published on 2022-06-012023-07-07 Journal: Acta neurologica Belgica [Category] COVID19(2023년), [키워드] COVID-19 Encephalopathy Mortality neurologic manifestations neurologic symptoms Prognosis [DOI] 10.1007/s13760-021-01851-7 PMC 바로가기
Posterior reversible encephalopathy syndrome – A pathology that should not be overlooked in the era of COVID-19후두 가역성 뇌병증 증후군 - 코로나19 시대에 간과해서는 안 될 병리학Case Reports Published on 2022-06-012022-09-11 Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Antibiotics Aphasia Autoimmune diseases blindness Case report cause Computed tomography coronavirus coronavirus disease Coronavirus disease 2019 cortical cortical blindness Corticosteroid Corticosteroids cough COVID-19 delta variant Department described determine diagnosed with COVID-19 Diagnosis dominant drugs Dyspnea eclampsia Emergency emergency department Encephalopathy Europe exhibiting exposure to Fever full recovery general practitioner generalized tonic-clonic seizures had no hypertensive Immediate Infectious disease Infectious diseases Invasion knowledge lobes material medical history MRI nervous system neurological Neurological complication Neurological complications Neurological symptom Neurological symptoms occipital Organ failure outcome pathology Patient patients with COVID-19 Pneumonia Posterior Posterior reversible encephalopathy syndrome PRES presenting radiological receiving renal resolved SARS-CoV-2 SARS-CoV-2 pneumonia secondary to Seizures Sepsis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe SARS Shortness of breath Symptom syndrome Thoracic Treatment variant [DOI] 10.1016/j.ajem.2022.03.005 PMC 바로가기 [Article Type] Case Reports
Rapidly progressive dementias — aetiologies, diagnosis and management Reviews Published on 2022-05-042022-10-05 Journal: Nature reviews. Neurology [Category] 바이오마커, 변종, 진단, 치료제, [키워드] addition aetiology antibody Biomarker cause clinically clinician cognitive condition contribute Dementia diagnosed Diagnosis diagnostic differential diagnoses disease Diseases disorder Encephalopathy epidemiological Factor help heterogeneous High-dose Immune-mediated include management morbidity and mortality neurodegenerative Potential treatment prion protocol reducing review RPD syndrome therapy treatable Treatment utility [DOI] 10.1038/s41582-022-00659-0 [Article Type] Reviews
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms감염 또는 신경학적 증상이 없는 대조군과 비교하여 COVID-19 감염 및 신경학적 증상이 있는 환자의 뇌척수액에서 바이러스 항원 및 염증성 바이오마커Article Published on 2022-05-022022-09-11 Journal: JAMA Network Open [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술, 치료법, [키워드] 95% CI age Antigen Biomarker capture Central nervous system cerebrospinal fluid clinical CNS component Concentration contribute Control control group controls correlated COVID COVID-19 COVID-19 infection COVID-19 severity cross-sectional cross-sectional study CSF Cytokines detectable disease severity Encephalopathy Evidence evidence of Gothenburg Health Organization healthy control highlight IL-10 IL-6 immune activation immune response immune responses immunoassay Infection Inflammatory Inflammatory biomarker inflammatory biomarkers Injury interferon interferon γ interleukin IQR male median microglobulin moderate Moderate COVID-19 Necrosis neurologic neuronal no differences nucleocapsid antigen Older outcome participant Participants Pathogenesis Patient patient groups platform Principal component principal component analysis Protein Sahlgrenska University Hospital SARS-COV-2 infection SARS-CoV-2 nucleocapsid scale severe COVID-19 severe disease significantly significantly higher Study protocol Swedish Symptom Symptoms test results Tumor tumor necrosis tumor necrosis factor tumor necrosis factor α Viral Viral antigen viral invasion Viral RNA was performed with COVID-19 World Health Organization β2-microglobulin [DOI] 10.1001/jamanetworkopen.2022.13253 PMC 바로가기 [Article Type] Article
Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer’s dementia입원한 COVID-19 환자와 정상 인지, 경도 인지 장애 또는 알츠하이머 치매가 있는 비 COVID-19 환자의 혈청 신경퇴행성 바이오마커 비교Article Published on 2022-05-012022-09-11 Journal: Alzheimer's & dementia : the journal of the Alzhei [Category] MERS, 바이오마커, [키워드] Acidic Alzheimer's disease amyloid beta Biomarker Biomarkers Cognitive impairment Complication Control correlated COVID COVID patient Covid patients COVID-19 COVID-19 patient Dementia died discharge home discharged home disease elevated Encephalopathy GFAp Glial fibrillary acidic protein hospitalized COVID-19 patient hospitalized COVID-19 patients In-hospital In-hospital death light chain marker Mild Mortality neurodegeneration neurodegenerative neurofilament light chain Neurological complications outcome Patient phosphorylated Protein SARS-CoV-2 serum severity significantly significantly lower subject survival tau. UCHL1 [DOI] 10.1002/alz.12556 PMC 바로가기 [Article Type] Article
Encephalopathy as a prognostic factor in adults with acute disseminated encephalomyelitis following COVID-19COVID-19에 따른 급성 파종성 뇌척수염 성인의 예후 인자로서의 뇌병증Case Reports Published on 2022-05-012022-09-11 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI absence Acute disseminated encephalomyelitis Acute necrotizing hemorrhagic leukoencephalitis ADEM affected ANHLE cerebrospinal fluid Clinical outcome clinical variable clinical variables COVID-19 Descriptive analysis Disseminated encephalomyelitis Encephalomyelitis Encephalopathy females Hemorrhagic Hemorrhagic Leukoencephalitis Infection Logistic regression median age morbidity and mortality Mortality Neurological symptoms Numerous observation Occurrence other variable other variables outcomes Patient patients performed predict Prognostic factor Prognostic factors proportion retrospective SARS-CoV-2 SARS-COV-2 infection Support Treatment variant worse prognosis [DOI] 10.1007/s00415-021-10947-2 PMC 바로가기 [Article Type] Case Reports
Optical coherence tomography as retinal imaging biomarker of neuroinflammation/neurodegeneration in systemic disorders in adults and children Reviews Published on 2022-04-152022-10-05 Journal: Eye (London, England) [Category] 바이오마커, [키워드] activated addressed Amyotrophic lateral sclerosis Ataxia Biomarker Central nervous system changes in children CNS complex Diabetes Mellitus disease Diseases disorder disorders domain Encephalopathy extension ganglion cell glial cell Human immunodeficiency virus hypoxic include Inflammatory invasive layer thickness lysosomal microglial cell Modification multiple sclerosis neurodegenerative neuronal Optical coherence tomography Retina retinal imaging Schizophrenia Spectral systemic and local systemic disorder tomography [DOI] 10.1038/s41433-022-02056-9 [Article Type] Reviews
CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term OutcomeCOVID-19 관련 뇌병증 및 뇌염의 CSF 바이오마커는 장기적인 결과를 예측합니다Article Published on 2022-04-112022-09-11 Journal: Frontiers in Immunology [Category] Coronavirus, COVID19(2023년), SARS, 바이오마커, [키워드] activity acute COVID-19 antibodies antibody Antigen antigens Autoimmunity blood-brain barrier both groups Complication coronavirus disease Coronavirus disease 2019 correlated COVID-19 CSF cytokine cytokine profile Cytokine storm syndrome Cytokines develop diagnostic elevated Encephalitis Encephalopathy evaluate Follow-up functional group healthy control healthy controls Hospitalized IgG IL-10 IL-18 IL-1ra IL-6 IL-8 in both groups include Inflammation Inflammatory Inflammatory cytokines inflammatory process IP-10 manifestation MCP1 MIG neuro-COVID neurofilaments neurologic Neurological involvement neuronal neuronal antibodies. no difference no differences outcome Patient patients predict pro-inflammatory cytokine pro-inflammatory cytokines Prognosis prognostic Proinflammatory cytokine proinflammatory cytokines promoted Protein SARS-CoV-2 SARS-COV-2 infection serum serum biomarker serum biomarkers severity significantly viral-induced while [DOI] 10.3389/fimmu.2022.866153 PMC 바로가기 [Article Type] Article
Neurological Sequelae of COVID-19Review Published on 2022-04-062023-07-09 Journal: Journal of integrative neuroscience [Category] COVID19(2023년), [키워드] Anxiety brain fog cerebral venous sinus thrombosis COVID-19 Depression Encephalitis Encephalopathy Guillain-barrè syndrome headache Hemorrhagic Stroke Ischemic Stroke Long COVID [DOI] 10.31083/j.jin2103077 [Article Type] Review